ctrl K

Watchlist Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

3.28

-0.19 (-5.48%)

At close: Jun 27, 2025, 3:59 PM

3.28

0.00%

After-hours: Jun 27, 2025, 05:50 PM EDT

Kyverna Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	7.03M	5.66M
Cost of Revenue	2.13M	1.71M	1.05M	586K
Gross Profit	n/a	-1.71M	5.97M	5.07M
Operating Income	-142.6M	-62.41M	-29.38M	-26.35M
Interest Income	15.36M	2.28M	565K	1K
Pretax Income	-127.48M	-60.37M	-28.89M	-26.35M
Net Income	-127.48M	-60.37M	-28.89M	-26.35M
Selling & General & Admin	30.13M	12.48M	8.01M	6.15M
Research & Development	110.34M	49.92M	28.4M	25.85M
Other Expenses	n/a	-55K	-9K	-2K
Operating Expenses	142.6M	62.41M	36.41M	32M
Interest Expense	142K	187K	65K	3K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	62.41M	36.41M	32M
Income Tax Expense	n/a	n/a	56K	1K
Shares Outstanding (Basic)	38.33M	673.62M	25.8M	25.8M
Shares Outstanding (Diluted)	38.33M	673.62M	25.8M	25.8M
EPS (Basic)	-3.33	-0.00	-1.12	-1.02
EPS (Diluted)	-3.33	-0.00	-1.12	-1.02
EBITDA	-142.6M	-58.47M	-27.78M	-25.76M
EBIT	-127.62M	-60.18M	-28.83M	-26.35M
Depreciation & Amortization	2.13M	1.71M	1.05M	586K